EuroMed Therapeutics is building the ninth Israeli
Post# of 85497
(Total Views: 471)
Posted On: 08/13/2019 8:40:28 AM
Re: breezerunner #12002
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion .
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
- Israeli Licensed Producer: EuroMed is building Israel’s ninth licensed producer, compared to more than 160 LPs across Canada.
- Low Cost Production: Israel has an ideal climate for year round outdoor cannabis production — significantly lowering costs.
- European End Markets: Israel’s strategic location makes it ideal for exporting to Europe, where consumers pay $18+ per gram.
- Access to Talent: Israel is a global leader in cannabis research, as well as a biotech and pharmaceutical hub.
https://euromedtherapeutics.com/
$$$$UNVC$$$$
(3)
(0)Univec Conglomerate Inc (UNVC) Stock Research Links
"An investment in knowledge pays the best interest."
Benjamin Franklin
All posts are my opinion only.
Benjamin Franklin
All posts are my opinion only.
Scroll down for more posts ▼